文献速递癫痫脑血管病

部署史对9·11后美国退伍军人癫痫与创伤性脑损伤关联的作用

Role of Deployment History on the Association Between Epilepsy and Traumatic Brain Injury in Post-9/11 Era US Veterans.
PubMed 文献 · Neurology · 2023-11-22

该队列纳入在退伍军人健康管理局和国防健康局系统均接受≥2年医疗服务的9·11后退伍军人共938,890人,其中27,436人(2.92%)患癫痫。采用逻辑回归模型分析部署史与各类TBI暴露对癫痫的交互作用,发现部署史对癫痫预测因素有显著差异影响:未部署退伍军人中重度/重度TBI与癫痫的关联更强,而穿透性TBI在部署退伍军人中关联更强。

要点

  • 9·11后退伍军人队列中癫痫患病率为2.92%(27,436/938,890)。
  • 未部署者癫痫更常见(3.85% vs 2.54%),部署者TBI更常见(33.94% vs 14.24%)。
  • 未部署者中度/重度TBI的癫痫aOR为2.92(95%CI 2.68-3.17),部署者为2.01(95%CI 1.91-2.11)。

核心结论

  • 部署史对癫痫预测因素有显著差异影响,穿透性TBI在部署退伍军人中癫痫关联更强,可能归因于战斗/爆炸暴露。
  • 部分癫痫预测因素(中度/重度TBI、多发性硬化、帕金森病)在未部署退伍军人中关联更强,提示潜在的健康战士效应。
  • 其他神经系统疾病(如脑肿瘤、阿尔茨海默病/额颞叶痴呆)在部署退伍军人中癫痫影响更大,可能归因于部署相关暴露。

研究设计与样本

  • 队列研究,纳入在退伍军人健康管理局和国防健康局系统均接受≥2年医疗服务的9·11后退伍军人,共938,890人。
  • 通过ICD-9/10-CM编码、抗癫痫药物及癫痫相关服务连接残疾认定癫痫。
  • 采用逻辑回归模型,纳入部署史与各疾病的交互项,校正人口学及军事特征。

主要发现

  • 队列共938,890人,其中27,436人(2.92%)患癫痫;70.64%有部署史。
  • 未部署退伍军人癫痫患病率为3.85%,部署退伍军人为2.54%。
  • 部署退伍军人TBI比例为33.94%,未部署退伍军人为14.24%。
  • 未部署退伍军人中度/重度TBI的癫痫aOR为2.92(95%CI 2.68-3.17),部署退伍军人为2.01(95%CI 1.91-2.11)。
  • 部署退伍军人穿透性TBI的癫痫aOR为5.33(95%CI 4.89-5.81);轻度TBI的癫痫 odds 按部署状态无显著差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Traumatic brain injury (TBI) is a well-established epilepsy risk factor and is common among service members. Deployment-related TBI, where combat/blast may be more common, may have different outcomes than nondeployment-related TBI. This work examined associations of all TBI exposures (not just combat), and epilepsy, while adjusting for comorbidities associated with epilepsy, among veterans by deployment status. METHODS: The cohort included post-9/11 veterans with ≥2 years of care in both Veterans Health Administration and Defense Health Agency systems. We identified epilepsy using ICD-9/10-CM codes, antiseizure medication, and service-connected disability for epilepsy. We conducted a logistic regression model with interaction terms for conditions by deployment history that adjusted for demographics and military characteristics. RESULTS: The cohort (n = 938,890) included post-9/11 veterans of whom 27,436 (2.92%) had epilepsy. Most veterans had a history of deployment (70.64%), referred to as "deployed." Epilepsy was more common among veterans who were never deployed ("nondeployed") (3.85% vs 2.54%). Deployed veterans were more likely to have had TBI, compared with the nondeployed veterans (33.94% vs 14.24%), but nondeployed veterans with moderate/severe TBI had higher odds of epilepsy compared with deployed veterans (adjusted odds ratio [aOR] 2.92, 95% CI 2.68-3.17 vs aOR 2.01, 95% CI 1.91-2.11). Penetrating TBI had higher odds of epilepsy among the deployed veterans (aOR 5.33, 95% CI 4.89-5.81), whereas the odds of epilepsy for mild TBI did not significantly differ by deployment status. Although most neurologic conditions were more prevalent among the nondeployed veterans, they were often associated with higher odds of epilepsy in the deployed veterans. DISCUSSION: Deployment history had a significant differential impact on epilepsy predictors. As expected, penetrating TBI had a greater epilepsy impact among deployed veterans perhaps due to combat/blast. Some epilepsy predictors (moderate/severe TBI, multiple sclerosis, and Parkinson disease) had a stronger association in the nondeployed veterans suggesting a potential healthy warrior effect in which such conditions preclude deployment. Other neurologic conditions (e.g., brain tumor, Alzheimer disease/frontotemporal dementia) had a greater epilepsy impact in the deployed veterans. This may be attributable to deployment-related exposures (combat injury, occupational exposures). A better understanding of deployment effects is critical to provide targeted epilepsy prevention in veterans and military service members.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Henion AK, Wang CP, Amuan M, et al. Role of Deployment History on the Association Between Epilepsy and Traumatic Brain Injury in Post-9/11 Era US Veterans. Neurology. 2023. PMID: 38030395. doi:10.1212/WNL.0000000000207943

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。